Amount
$109,458,800
Recipient
Takeda Pharmaceuticals Australia Pty Ltd
Company — NSW
Selection Process
Direct Award
Period
31 Dec 2019 — 29 Jun 2025
Approved: 17 Dec 2020

Purpose

Procurement method: Limited tender

Program

National Blood Authority

National Blood Authority

Other Grants to Takeda Pharmaceuticals Australia Pty Ltd

GrantProgramAmountSelection
National Supply arrangement for imported immunoglobulin products National Blood Authority $434,085,725 Direct Award
Imported Plasma and Recombinant Products National Blood Authority $30,209,374 Direct Award
Procurement of Imported Plasma and Recombinant Products (IPRP) … National Blood Authority $22,323,958 Open Competitive

Data Source

Source: AusTender
Category: UNSPSC 51000000
State: NSW | Postcode: 2000